As an addition to the "way of thinking" discussion as it pertains to boutique pharma companies...I would never want to invest (remember investing and gambling differ) my $$ with a firm whose revenue, income, hopes and dreams are riding on the FDA approval of one product. Not saying the one you mentioned is, as like Greg, I know nothing about the company.
These firms are not valued the way most best-of-breed companies you've seen discussed in this thread are. So might you miss out on a 400% gain when the new product gets green lit through the final stage of FDA approval? Sure...but you might also miss out on a 50+% loss when the thing dies on the vine since the market knows their product pipeline had nothing else in it.
__________________
Jeff: Project "Rolling Mockup" 69 Camaro SS, AFX, TKO600, Baer GT, etc
|